Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7125)
All Articles published online
|
Nov 7, 2011 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li P, Wang SS, Liu H, Li N, McNutt MA, Li G, Ding HG. Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World J Gastroenterol 2011; 17(41): 4563-4571 [PMID: 22147961 DOI: 10.3748/wjg.v17.i41.4563] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i41/4563.htm |
| Number | Citing Articles |
| 1 |
Jun-yi Shen, Chuan Li, Tian-fu Wen, Lv-nan Yan, Bo Li, Wen-tao Wang, Jia-yin Yang, Ming-qing Xu. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. Journal of Surgical Research 2017; 209: 102 doi: 10.1016/j.jss.2016.10.005
|
| 2 |
N. P. Teryukova, G. I. Blinova, V. A. Ivanov. Zajdela hepatoma cells cultured in vitro. Cell and Tissue Biology 2013; 7(3): 245 doi: 10.1134/S1990519X13030127
|
| 3 |
Kiyoshi Ohkawa, Tadashi Asakura, Yutaka Tsukada, Tomokazu Matsuura. Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments. International Journal of Oncology 2017; 50(6): 2180 doi: 10.3892/ijo.2017.3982
|
| 4 |
Kenji Ikeda, Masatoshi Kudo, Seiji Kawazoe, Yukio Osaki, Masafumi Ikeda, Takuji Okusaka, Toshiyuki Tamai, Takuya Suzuki, Takashi Hisai, Seiichi Hayato, Kiwamu Okita, Hiromitsu Kumada. Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma. Journal of Gastroenterology 2017; 52(4): 512 doi: 10.1007/s00535-016-1263-4
|
| 5 |
Mohamed Abd El‐Fattah, Mohamed Aboelmagd, Mohammed Elhamouly. Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population‐based study. United European Gastroenterology Journal 2017; 5(2): 227 doi: 10.1177/2050640616659024
|
| 6 |
Junwei Chen, Lisha Lai, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10361-5
|
| 7 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_2-1
|
| 8 |
Alok Ghosh Chaudhuri, Saptadip Samanta, Monalisha Dey, N. S. Raviraja, Souvik Dey.
Role of Alpha-Fetoprotein in the Pathogenesis of Cancer
. Journal of Environmental Pathology, Toxicology and Oncology 2024; 43(2): 57 doi: 10.1615/JEnvironPatholToxicolOncol.2023049145
|
| 9 |
Chao Zhang, Xiangmei Chen, Hui Liu, Hui Li, Wei Jiang, Wenting Hou, Michael A. McNutt, Fengmin Lu, Gang Li. Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm. International Journal of Cancer 2015; 137(8): 1818 doi: 10.1002/ijc.29548
|
| 10 |
Hong Liu, Yiyang Xu, Jingyi Xiang, Li Long, Shon Green, Zhiyuan Yang, Bryan Zimdahl, Jingwei Lu, Neal Cheng, Lucas H. Horan, Bin Liu, Su Yan, Pei Wang, Juan Diaz, Lu Jin, Yoko Nakano, Javier F. Morales, Pengbo Zhang, Lian-xing Liu, Binnaz K. Staley, Saul J. Priceman, Christine E. Brown, Stephen J. Forman, Vivien W. Chan, Cheng Liu. Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer. Clinical Cancer Research 2017; 23(2): 478 doi: 10.1158/1078-0432.CCR-16-1203
|
| 11 |
Narongsak Rungsakulkij, Wikran Suragul, Somkit Mingphruedhi, Pongsatorn Tangtawee, Paramin Muangkaew, Suraida Aeesoa. Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection. World Journal of Clinical Cases 2018; 6(6): 110-120 doi: 10.12998/wjcc.v6.i6.110
|
| 12 |
Wei Li, Kun Liu, Yi Chen, Mingyue Zhu, Mengsen Li. Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance. Current Medicinal Chemistry 2021; 28(6): 1126 doi: 10.2174/0929867327999200729151247
|
| 13 |
Wissam Zam, Amany Assaad. Chimeric Antigen Receptor T-cells (CARs) in Cancer Treatment. Current Molecular Pharmacology 2022; 15(3): 532 doi: 10.2174/1874467214666210811150255
|
| 14 |
Wen-jun Ma, Hai-yong Wang, Li-song Teng. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World Journal of Surgical Oncology 2013; 11(1) doi: 10.1186/1477-7819-11-212
|
| 15 |
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, Alireza Abbaspour, Amirhossein Zabolian, Salar Javanshir, Mehrnaz Razzazan, Sepideh Mirzaei, Maliheh Entezari, Mohammad Ali Shekhi Beig Goharrizi, Shokooh Salimimoghadam, Amir Reza Aref, Alireza Kalbasi, Romina Rajabi, Mohsen Rashidi, Afshin Taheriazam, Gautam Sethi. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges. Pharmacological Research 2023; 187: 106553 doi: 10.1016/j.phrs.2022.106553
|
| 16 |
Adriana Toro, Annalisa Ardiri, Maurizio Mannino, Maria Concetta Arcerito, Giovanni Mannino, Filippo Palermo, Gaetano Bertino, Isidoro Di Carlo. Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study. BMC Surgery 2014; 14(1) doi: 10.1186/1471-2482-14-40
|
| 17 |
Jing-Hang Jiang, Zhe Guo, Hao-Feng Lu, Xiao-Bo Wang, Hao-Jie Yang, Fu-Quan Yang, Si-Yang Bao, Jian-Hong Zhong, Le-Qun Li, Ri-Rong Yang, Bang-De Xiang. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis. World Journal of Gastroenterology 2015; 21(15): 4627-4634 doi: 10.3748/wjg.v21.i15.4627
|
| 18 |
Xiaoping Wang, Qiaoxia Wang. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/9049252
|
| 19 |
D. Reim, Y.-S. Choi, H.M. Yoon, B. Park, B.W. Eom, M.-C. Kook, K.W. Ryu, I.J. Choi, J. Joo, Y.-W. Kim. Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection. European Journal of Surgical Oncology (EJSO) 2017; 43(8): 1542 doi: 10.1016/j.ejso.2017.04.005
|
| 20 |
Yu-Liang Huang, Jun-Rong Wu, Min Fang, Hui-Liu Zhao, Zhi-Min Liu, Jian Ye, Ling-Sha Huang, Bo Zhu. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma. Medicine 2019; 98(14): e15090 doi: 10.1097/MD.0000000000015090
|
| 21 |
Chao Zhang, Jiangtao Zhang, Jing Wang, Ying Yan, Chuanbao Zhang. Alpha‐fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl‐2 gene expression through an RA‐RAR signalling pathway. Journal of Cellular and Molecular Medicine 2020; 24(23): 13804 doi: 10.1111/jcmm.15962
|
| 22 |
K Sideras, S J Bots, K Biermann, D Sprengers, W G Polak, J N M IJzermans, R A de Man, Q Pan, S Sleijfer, M J Bruno, J Kwekkeboom. Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area. British Journal of Cancer 2015; 112(12): 1911 doi: 10.1038/bjc.2015.92
|
| 23 |
Faryal Mehwish Awan, Anam Naz, Ayesha Obaid, Amjad Ali, Jamil Ahmad, Sadia Anjum, Hussnain Ahmed Janjua, Alessandro Weisz. Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach. PLOS ONE 2015; 10(9): e0138913 doi: 10.1371/journal.pone.0138913
|
| 24 |
Kangshun Zhu, Jingjun Huang, Lisha Lai, Wensou Huang, Mingyue Cai, Jingwen Zhou, Yongjian Guo, Junwei Chen. Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation. Radiology 2018; 288(1): 300 doi: 10.1148/radiol.2018172028
|
| 25 |
Sarfaraz Alam, Sadaf Nasreen, Ateeque Ahmad, Mahendra Pandurang Darokar, Feroz Khan. Detection of Natural Inhibitors against Human Liver Cancer Cell Lines through QSAR, Molecular Docking and ADMET Studies. Current Topics in Medicinal Chemistry 2021; 21(8): 686 doi: 10.2174/1568026620666201204155830
|
| 26 |
G. Martínez-Mier, S. Esquivel-Torres, A. Nava-Lacorte, F.A. Lajud-Barquín, S. Zilli-Hernández, L.M. Vázquez-Ramírez. Correlación de los niveles de alfafetoproteína sérica preoperatoria y sobrevida en el tratamiento quirúrgico del hepatocarcinoma en una unidad médica de alta especialidad en Veracruz, México. Revista de Gastroenterología de México 2017; 82(4): 357 doi: 10.1016/j.rgmx.2017.03.009
|
| 27 |
A N L L Lalisang, W S Jeo, Y Moenadjat, T J M Lalisang. Correlation Between Serum Level of Alpha-Fetoprotein and Histological Differentiation Grade of Hepatocellular Carcinoma. Journal of Physics: Conference Series 2018; 1073: 032056 doi: 10.1088/1742-6596/1073/3/032056
|
| 28 |
Hyunyou Kim, So Jeong Lee, Myunghee Yoon. Alpha-fetoprotein is correlated with intrahepatic recurrence of hepatocellular carcinoma after a hepatectomy. Annals of Surgical Treatment and Research 2020; 98(4): 168 doi: 10.4174/astr.2020.98.4.168
|
| 29 |
Xiaonan Ji, Yanli Shen, Hao Sun, Xiangdong Gao. A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel. Tumor Biology 2016; 37(8): 10085 doi: 10.1007/s13277-016-4803-x
|
| 30 |
Hao Xing, Haibo Qiu, Xuemei Ding, Jun Han, Zhenli Li, Han Wu, Cunling Yan, Huijun Li, Ruilin Han, Han Zhang, Chao Li, Mingda Wang, Mengchao Wu, Feng Shen, Yijie Zheng, Tian Yang. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma. Biomarkers in Medicine 2019; 13(7): 545 doi: 10.2217/bmm-2018-0414
|
| 31 |
Sukru Emre, Veysel Umman, Manuel Rodriguez‐Davalos. Current concepts in pediatric liver tumors. Pediatric Transplantation 2012; 16(6): 549 doi: 10.1111/j.1399-3046.2012.01704.x
|
| 32 |
Imran Khan, Mohammad Khalid Zakaria, Mukesh Kumar, Prashant Mani, Parthaprasad Chattopadhyay, Debi P Sarkar, Subrata Sinha. A novel placental like alkaline phosphate promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0602-1
|
| 33 |
Shanshan Wang, Mingyue Zhu, Qiaoyun Wang, Yuli Hou, Lei Li, Honglei Weng, Yan Zhao, Dexi Chen, Huiguo Ding, Junli Guo, Mengsen Li. Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling. Cell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-1036-5
|
| 34 |
Guanghua Liu, Kui Wang, Jun Li, Yong Xia, Lihua Lu, Xuying Wan, Zhenlin Yan, Lehua Shi, Wan Yee Lau, Mengchao Wu, Feng Shen. Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomy. Journal of Gastroenterology and Hepatology 2015; 30(9): 1405 doi: 10.1111/jgh.12953
|
| 35 |
María Luisa Hernández-Bule, María Ángeles Trillo, Alejandro Úbeda, Irina V. Lebedeva. Molecular Mechanisms Underlying Antiproliferative and Differentiating Responses of Hepatocarcinoma Cells to Subthermal Electric Stimulation. PLoS ONE 2014; 9(1): e84636 doi: 10.1371/journal.pone.0084636
|
| 36 |
Junwei Chen, Lisha Lai, Qu Lin, Wensou Huang, Mingyue Cai, Kangshun Zhu, Mingsheng Huang. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study. Oncotarget 2017; 8(1): 408 doi: 10.18632/oncotarget.13427
|
| 37 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 27 doi: 10.1007/978-3-319-26956-6_2
|
| 38 |
Ekaterina Zubkova, Lidiya Semenkova, Elena Dudich, Igor Dudich, Yelena Parfyonova, Mikhail Menshikov. RETRACTED ARTICLE: Alpha-fetoprotein contributes to THP-1 cell invasion and chemotaxis via protein kinase and Gi-protein-dependent pathways. Molecular and Cellular Biochemistry 2013; 379(1-2): 283 doi: 10.1007/s11010-013-1650-6
|
| 39 |
Uta Fernekorn, Jörg Hampl, Frank Weise, Maren Klett, Annette Läffert, Karin Friedel, Andreas Schober. Microfluidic 3D HepG2 cell culture: Reproducing hepatic tumor gene and protein expression in in vitro scaffolds. Engineering in Life Sciences 2015; 15(3): 340 doi: 10.1002/elsc.201400083
|
| 40 |
Song-Lin An, Ting Xiao, Li-Ming Wang, Wei-Qi Rong, Fan Wu, Li Feng, Fa-Qiang Liu, Fei Tian, Jian-Xiong Wu. Prognostic Significance of Preoperative Serum Alpha-fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China. Asian Pacific Journal of Cancer Prevention 2015; 16(10): 4421 doi: 10.7314/APJCP.2015.16.10.4421
|
| 41 |
Gaetano Bertino, Annalisa Ardiri, Michele Malaguarnera, Giulia Malaguarnera, Nicoletta Bertino, Giuseppe Stefano Calvagno. Hepatocellualar Carcinoma Serum Markers. Seminars in Oncology 2012; 39(4): 410 doi: 10.1053/j.seminoncol.2012.05.001
|
| 42 |
G. Martínez-Mier, S. Esquivel-Torres, A. Nava-Lacorte, F.A. Lajud-Barquín, S. Zilli-Hernández, L.M. Vázquez-Ramírez. Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico. Revista de Gastroenterología de México (English Edition) 2017; 82(4): 357 doi: 10.1016/j.rgmxen.2017.09.001
|
| 43 |
Rita Ammoury, Roula Tahtouh, Nadine Mahfouz, Raia Doumit, Charbel Khalil, George Hilal. Relationship between Protein kinase C isoforms, Telomerase and Alpha-fetoprotein through PI3K/AKT/mTOR pathway in Hepatocellular carcinoma. MedPharmRes 2021; 5(4): 12 doi: 10.32895/UMP.MPR.5.4.3
|